• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Thomas H. Lee Partners Appoints Paul Black As a Consultant for Healthcare Group

    10/11/22 9:00:00 AM ET
    $CERN
    $HQY
    $MDRX
    Managed Health Care
    Health Care
    Business Services
    Consumer Discretionary
    Get the next $CERN alert in real time by email

    Healthcare IT Industry Expert Will Support the Firm's HCIT Strategy

    Thomas H. Lee Partners, L.P. ("THL"), a premier private equity firm investing in middle-market growth companies, today announced the appointment of Paul Black as a consultant for the firm's healthcare investment group. Black, who brings more than 25 years of experience leading companies in healthcare information technology ("Healthcare IT"), will support the team's efforts in identifying, sourcing, and growing investment opportunities across the healthcare market.

    "We are very pleased to welcome Paul to THL as a consultant for the firm's healthcare group," said Shahab Vagefi, Managing Director at THL. "THL has had a longstanding focus in healthcare and technology. As we continue finding investment opportunities at the intersection of these industries, Paul's significant experience creating and executing a strategic vision for businesses in Healthcare IT will be greatly beneficial as we add more high-quality companies seeking to improve the healthcare ecosystem to our portfolio."

    In this role, Black will support the healthcare group in deal sourcing, due diligence for potential investments, and developing new relationships with founders and management teams across the healthcare landscape. He will also serve as an advisor to portfolio companies to support their growth.

    "THL's thesis-driven approach and dedicated focus on Healthcare IT has enabled it to work with unique companies across the healthcare landscape," said Paul Black. "I am pleased to join such an exceptional team and look forward to advancing the firm's strategy."

    Prior to joining THL, Black served 10 years as a Director and CEO of Allscripts, (NASDAQ:MDRX) a global leader in healthcare information technology solutions. Before that, he was the COO of Cerner Corporation (NASDAQ:CERN) for more than a decade. Black is currently a director of HealthEquity (NASDAQ:HQY), Community CareLink, The Advancement Board University of Kansas Health System and The Harry S. Truman Presidential Library & Museum.

    About Thomas H. Lee Partners, L.P.

    Thomas H. Lee Partners, L.P. ("THL") is a premier private equity firm investing in middle-market growth companies exclusively within three sectors: Healthcare, Financial Technology & Services, and Technology & Business Solutions. THL couples deep sector expertise through an Identified Sector Opportunity ("ISO") process with dedicated internal operating resources from its Strategic Resource Group ("SRG") to transform and build great companies of lasting value in partnership with management. The Firm's domain expertise and resources help to build great companies with an aim to accelerate growth, improve operations and drive long-term sustainable value. THL has been an active investor in Healthcare and Healthcare IT for decades with investments in Intelligent Medical Objects, Nextech, Qventus, Intermedix, SeniorLink and numerous other Healthcare and Technology companies. Since 1974, THL has raised more than $34 billion of equity capital, invested in over 160 companies and completed more than 500 add-on acquisitions representing an aggregate enterprise value at acquisition of over $210 billion.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221011005107/en/

    Get the next $CERN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CERN
    $HQY
    $MDRX

    CompanyDatePrice TargetRatingAnalyst
    HealthEquity Inc.
    $HQY
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    HealthEquity Inc.
    $HQY
    12/4/2024$126.00Outperform
    Mizuho
    HealthEquity Inc.
    $HQY
    11/15/2024$108.00Neutral
    Goldman
    HealthEquity Inc.
    $HQY
    4/4/2024$101.00Mkt Outperform
    JMP Securities
    HealthEquity Inc.
    $HQY
    4/2/2024$86.00 → $108.00Overweight
    JP Morgan
    Veradigm Inc.
    $MDRX
    3/19/2024$15.00 → $10.00Buy → Hold
    Deutsche Bank
    Veradigm Inc.
    $MDRX
    1/3/2024$11.00Equal Weight
    Barclays
    HealthEquity Inc.
    $HQY
    1/3/2024$84.00Overweight
    Barclays
    More analyst ratings

    $CERN
    $HQY
    $MDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Veradigm Inc.

      SC 13G - Veradigm Inc. (0001124804) (Subject)

      11/14/24 4:05:58 PM ET
      $MDRX
      EDP Services
      Technology
    • Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

      SC 13G/A - Veradigm Inc. (0001124804) (Subject)

      11/14/24 1:11:13 PM ET
      $MDRX
      EDP Services
      Technology
    • Amendment: SEC Form SC 13G/A filed by Veradigm Inc.

      SC 13G/A - Veradigm Inc. (0001124804) (Subject)

      11/8/24 10:29:29 AM ET
      $MDRX
      EDP Services
      Technology

    $CERN
    $HQY
    $MDRX
    SEC Filings

    See more
    • HealthEquity Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

      4/28/25 4:01:38 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • SEC Form 8-K filed by Veradigm Inc.

      8-K - Veradigm Inc. (0001124804) (Filer)

      4/22/25 4:23:28 PM ET
      $MDRX
      EDP Services
      Technology
    • SEC Form 8-K filed by Veradigm Inc.

      8-K - Veradigm Inc. (0001124804) (Filer)

      4/17/25 5:02:25 PM ET
      $MDRX
      EDP Services
      Technology

    $CERN
    $HQY
    $MDRX
    Leadership Updates

    Live Leadership Updates

    See more
    • Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership

      Appoints Jonathan Sacks and Bruce Felt to the Board Lou Silverman to Succeed Greg Garrison as Chairman Veradigm Inc. (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the "Board") appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of the Board upon Mr. Garrison's retirement. Further, independent director Vinit Asar has been named Chair of the Nominating and Go

      3/18/25 4:47:00 PM ET
      $CMBM
      $DOMO
      $EVH
      $MDRX
      Radio And Television Broadcasting And Communications Equipment
      Technology
      Computer Software: Prepackaged Software
      Other Consumer Services
    • Veradigm Announces Board Expansion and Changes

      Appoints Vinit Asar and Louis Silverman to its Board of Directors Agrees to Add Two Additional Directors Veradigm® (OTC:MDRX) ("Veradigm" or the "Company"), a leading provider of healthcare data and technology solutions, announced today it has entered into a Cooperation Agreement (the "Agreement") with Kent Lake PR LLC ("Kent Lake"). The Agreement aligns with the Board's request for input from shareholders regarding board composition on January 30, 2025, and a desire to conduct an orderly refreshment of the Board following the conclusion of the exploration of strategic alternatives. As part of the Agreement, the Board has appointed two new independent directors, Vinit Asar and Louis Silve

      2/20/25 4:02:00 PM ET
      $MDRX
      $OCX
      $ZIMV
      EDP Services
      Technology
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
    • HealthEquity Reports Year-End Sales Metrics

      DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,

      2/18/25 4:01:00 PM ET
      $HQY
      Business Services
      Consumer Discretionary

    $CERN
    $HQY
    $MDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Langan Thomas covered exercise/tax liability with 1,893 shares, decreasing direct ownership by 0.57% to 327,528 units (SEC Form 4)

      4 - Veradigm Inc. (0001124804) (Issuer)

      5/5/25 4:08:52 PM ET
      $MDRX
      EDP Services
      Technology
    • Director Selander Robert W exercised 12,500 shares at a strike of $28.68 and sold $446,513 worth of shares (5,750 units at $77.65), increasing direct ownership by 9% to 84,969 units (SEC Form 4)

      4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

      4/11/25 12:53:52 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • FOUNDER AND VICE CHAIRMAN Neeleman Stephen covered exercise/tax liability with 9,019 shares, decreasing direct ownership by 7% to 113,642 units (SEC Form 4)

      4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

      4/10/25 5:13:19 PM ET
      $HQY
      Business Services
      Consumer Discretionary

    $CERN
    $HQY
    $MDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4) (Amendment)

      4/A - Veradigm Inc. (0001124804) (Issuer)

      3/15/24 5:16:45 PM ET
      $MDRX
      EDP Services
      Technology
    • Stonehill Capital Management Llc bought $66,001,500 worth of shares (10,222,875 units at $6.46) (SEC Form 4)

      4 - Veradigm Inc. (0001124804) (Issuer)

      3/4/24 9:50:46 PM ET
      $MDRX
      EDP Services
      Technology

    $CERN
    $HQY
    $MDRX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • USA Today Names HealthEquity to its Top 25 Workplaces

      DRAPER, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the nation's largest health savings account (HSA) administrator, today announced it has been named a USA Today Top Workplace for 2025, ranking 23rd nationwide for companies with more than 2,500 employees. This is HealthEquity's fourth consecutive year on the coveted list, and it is the only company from the healthcare benefits industry to be ranked in the Top 25. "This award is a testament to our incredible teammates who show up every day—wherever they are—with purpose, passion, and care for one another. They've proven that a thriving culture isn't bound by office walls. It's built through t

      4/29/25 9:00:00 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • STAAR Surgical Announces Changes to Board of Directors

      STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

      4/24/25 5:00:00 PM ET
      $AZN
      $CRVL
      $LLY
      $MDRX
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Specialty Insurers
      Finance
    • HealthEquity's Expedited Claims Technology Wins Artificial Intelligence Excellence Awards

      DRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity"), the nation's largest Health Savings Account (HSA) administrator, has been recognized by the Business Intelligence Group for its Expedited Claims AI system at the 2025 Artificial Intelligence Excellence Awards. The award honors outstanding organizations, products, and individuals who have harnessed the power of AI for good to solve real-world problems. HealthEquity won awards for "Innovative AI Products" in the categories of health and automation. "Our team identified a pain point for members, and they determined a way to fix it," said Bryan Rhodes, principal product manager at HealthEqu

      4/15/25 9:20:00 AM ET
      $HQY
      Business Services
      Consumer Discretionary

    $CERN
    $HQY
    $MDRX
    Financials

    Live finance-specific insights

    See more

    $CERN
    $HQY
    $MDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • STAAR Surgical Announces Changes to Board of Directors

      STAAR Surgical Company (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company's Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has chosen not to stand for re-election to the Board when her term expires at the Company's 2025 annual meeting of shareholders in June. In addition, the Company announced that Wei Jiang, who has served as a director since 2024, has agreed to

      4/24/25 5:00:00 PM ET
      $AZN
      $CRVL
      $LLY
      $MDRX
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Specialty Insurers
      Finance
    • HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results

      Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24.Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24.Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to $2.25 in FY24.Adjusted EBITDA of $471.8 million, an increase of 28% compared to $369.2 million in FY24.9.9 million HSAs, an increase of 14% compared to FY24.Total HSA Assets of $32.1 billion, an increase of 27% compared to F

      3/18/25 4:01:00 PM ET
      $HQY
      Business Services
      Consumer Discretionary
    • Veradigm to Release Financial Update March 18th and Host Investor Call March 19th

      Veradigm® (OTC:MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a financial update after the close of regular stock market hours on March 18, 2025. Veradigm management plans to host an investor conference call and webcast to discuss the Company's update at 8:00 a.m. Eastern Time on March 19, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regular stock market hours on Tuesday, March 18, 2025. The announcement will also be available at the Veradigm investor relations website. To listen to the conference call, participants may log onto the Veradigm investor relations we

      3/13/25 9:57:00 PM ET
      $MDRX
      EDP Services
      Technology
    • HealthEquity upgraded by Raymond James with a new price target

      Raymond James upgraded HealthEquity from Outperform to Strong Buy and set a new price target of $115.00 from $120.00 previously

      3/25/25 8:22:31 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • Mizuho initiated coverage on HealthEquity with a new price target

      Mizuho initiated coverage of HealthEquity with a rating of Outperform and set a new price target of $126.00

      12/4/24 7:41:08 AM ET
      $HQY
      Business Services
      Consumer Discretionary
    • Goldman initiated coverage on HealthEquity with a new price target

      Goldman initiated coverage of HealthEquity with a rating of Neutral and set a new price target of $108.00

      11/15/24 7:47:14 AM ET
      $HQY
      Business Services
      Consumer Discretionary